Sawhney Roger
- SEC CIK
- 0001858748
No open-market purchases or sales filed in the past year.
Current role at each company
- ABUS Arbutus Biopharma CorpDirectoras of Sep 23, 2026
- ACTU Actuate Therapeutics, Inc.Directoras of May 22, 2026
- ALIM Alimera Sciences IncDirectoras of Mar 1, 2023
- OMGA Omega Therapeutics, Inc.Chief Financial Officeras of Mar 11, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sawhney Roger as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OMGA Omega Therapeutics, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 (view filing) | Aug 3 | Same day | Sawhney RogerChief Financial Officer | PPurchase | +2.94K | $17.00 | +$50.0K | New position2.94K after |